Craven House Capital (CRV) Competitors GBX 0.19 +0.02 (+8.57%) As of 04/15/2025 11:16 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock CRV vs. ALGW, D467, BRH, CMB, CCPE, WSL, OTT, NCA, STHP, and AMIFShould you be buying Craven House Capital stock or one of its competitors? The main competitors of Craven House Capital include Alpha Growth (ALGW), Thames Ventures VCT 2 DP67 (D467), Braveheart Investment Group (BRH), Cambria Africa (CMB), CVC Credit Partners European Opportunities (CCPE), Worldsec (WSL), Oxford Technology 3 Venture Capital Trust (OTT), New Century AIM VCT (NCA), Stranger (STHP), and Amicorp FS (AMIF). These companies are all part of the "asset management" industry. Craven House Capital vs. Alpha Growth Thames Ventures VCT 2 DP67 Braveheart Investment Group Cambria Africa CVC Credit Partners European Opportunities Worldsec Oxford Technology 3 Venture Capital Trust New Century AIM VCT Stranger Amicorp FS Craven House Capital (LON:CRV) and Alpha Growth (LON:ALGW) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, community ranking, institutional ownership, earnings and analyst recommendations. Which has more volatility and risk, CRV or ALGW? Craven House Capital has a beta of -0.06, suggesting that its share price is 106% less volatile than the S&P 500. Comparatively, Alpha Growth has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Which has stronger earnings and valuation, CRV or ALGW? Craven House Capital has higher earnings, but lower revenue than Alpha Growth. Craven House Capital is trading at a lower price-to-earnings ratio than Alpha Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCraven House CapitalN/AN/A-£11.40K-£0.00-6,440.68Alpha Growth£4.16M0.69-£1.60M-£0.32-1.84 Does the MarketBeat Community believe in CRV or ALGW? Craven House Capital received 32 more outperform votes than Alpha Growth when rated by MarketBeat users. However, 75.00% of users gave Alpha Growth an outperform vote while only 70.67% of users gave Craven House Capital an outperform vote. CompanyUnderperformOutperformCraven House CapitalOutperform Votes5370.67% Underperform Votes2229.33% Alpha GrowthOutperform Votes2175.00% Underperform Votes725.00% Does the media favor CRV or ALGW? In the previous week, Craven House Capital's average media sentiment score of 0.00 equaled Alpha Growth'saverage media sentiment score. Company Overall Sentiment Craven House Capital Neutral Alpha Growth Neutral Is CRV or ALGW more profitable? Craven House Capital has a net margin of 0.00% compared to Alpha Growth's net margin of -38.47%. Craven House Capital's return on equity of 0.02% beat Alpha Growth's return on equity.Company Net Margins Return on Equity Return on Assets Craven House CapitalN/A 0.02% -3.05% Alpha Growth -38.47%-27.36%-0.18% Do insiders & institutionals have more ownership in CRV or ALGW? 3.3% of Craven House Capital shares are owned by institutional investors. Comparatively, 5.2% of Alpha Growth shares are owned by institutional investors. 34.3% of Craven House Capital shares are owned by insiders. Comparatively, 54.6% of Alpha Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryAlpha Growth beats Craven House Capital on 7 of the 12 factors compared between the two stocks. Remove Ads Get Craven House Capital News Delivered to You Automatically Sign up to receive the latest news and ratings for CRV and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRV vs. The Competition Export to ExcelMetricCraven House CapitalAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£734,000.00£1.08B£3.66B£2.47BDividend Yield2.57%4.44%4.20%4.95%P/E Ratio-6,440.6823.9213.95130.51Price / SalesN/A2,219.671,654.21230,385.31Price / Cash1.4060.9450.1927.95Price / Book-0.011.093.324.42Net Income-£11,399.98£260.34M£1.23B£5.79B7 Day Performance8.57%8.70%5.25%5.37%1 Month Performance8.57%-0.24%4.89%3.79%1 Year PerformanceN/A1.26%8.93%104.20% Craven House Capital Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVCraven House CapitalN/AGBX 0.19+8.6%N/AN/A£734,000.00N/A-6,440.683Gap UpALGWAlpha GrowthN/AGBX 0.57-0.9%N/A-50.3%£2.74M£4.16M-1.764Gap UpD467Thames Ventures VCT 2 DP67N/AN/AN/AN/A£2.69MN/A-1,200.00N/AGap DownBRHBraveheart Investment GroupN/AGBX 3.94-1.5%N/A-41.4%£2.51M£1.24M-0.395Gap UpCMBCambria AfricaN/AN/AN/AN/A£2.45M£1.41M-3.759CCPECVC Credit Partners European OpportunitiesN/AN/AN/AN/A£2.13MN/A0.00N/AGap DownWSLWorldsecN/AGBX 2flatN/AN/A£2.13M£-270,215.86-2.65N/AOTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M£-85,000.00-12.59203Gap DownNCANew Century AIM VCTN/AN/AN/AN/A£2.00M£-2,760,000.00-68.92N/ASTHPStrangerN/AN/AN/AN/A£2.00MN/A0.00N/AAMIFAmicorp FSN/AGBX 1.60flatN/AN/A£1.92M£14.47M3.27108 Remove Ads Related Companies and Tools Related Companies Alpha Growth Alternatives Thames Ventures VCT 2 DP67 Alternatives Braveheart Investment Group Alternatives Cambria Africa Alternatives CVC Credit Partners European Opportunities Alternatives Worldsec Alternatives Oxford Technology 3 Venture Capital Trust Alternatives New Century AIM VCT Alternatives Stranger Alternatives Amicorp FS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRV) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Craven House Capital Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Craven House Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.